Tracking a cancer Drug's Real-World impact on Patients' lives
NCT ID NCT05326308
Summary
This study aims to understand how the drug zanubrutinib works for adults with certain blood cancers in everyday clinic settings, not a controlled trial. It will follow about 705 patients to see how the treatment affects their quality of life, how often they need hospital care, and how well the cancer responds. The goal is to gather practical information to help doctors and patients make better treatment decisions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC LYMPHOCYTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Lübecker Onkologische Schwerpunktpraxis
RECRUITINGLübeck, Schleswig-Holstein, D-23562, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Universitätsklinikum Salzburg, Klinik für Innere Medizin III
RECRUITINGSalzburg, A-5020, Austria
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.